German cartel office to probe DFL licensing in 50+1 rule case yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
“When I look at AI, I see only monopolies. Nothing else.” These extraordinary words from Andreas Mundt, head of the German Competition Authority, capture a mounting European push to regulate the
Part 2 Summary of American Bar Association Antitrust Law Section natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
German antitrust regulators have approved the takeover of German biotech company Morphosys by the Swiss pharmaceutical firm Novartis. Germany's Federal Cartel Office announced its approval of the transaction on Tuesday. Morphosys, which is headquartered near Munich, manufactures drugs to treat the blood cancers leukaemia. Andreas Mundt, who heads the regulatory agency, said officials had examined very carefully whether the merger would affect competition in the research and development of new dr
Ensuring competition in AI will also preserve democracy, experts say euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.